The general consensus in the literature is that ADA enzyme levels are higher in schizophrenia patients than in healthy populations (Brunstein et al. 2007; Dutra et al. 2010; Ghaleiha et al. 2011; O’Donovan et al. 2018). The gene discussed is ADA; the disease is schizophrenia.